Mismatch repair deficiency and MUTYH variants in small intestine-neuroendocrine tumors

被引:4
|
作者
Helderman, Noah C. [1 ]
Elsayed, Fadwa A. [2 ]
van Wezel, Tom [2 ]
Terlouw, Diantha [1 ,2 ]
Langers, Alexandra M. J. [3 ]
van Egmond, Demi [2 ]
Kilinc, Guel [4 ]
Hristova, Hristina [1 ]
Sarasqueta, Arantza Farina [5 ]
Morreau, Hans [2 ]
Nielsen, Maartje [1 ]
Suerink, Manon [1 ]
机构
[1] Leiden Univ Med Ctr, Dept Clin Genet, NL-2333 ZA Leiden, Netherlands
[2] Leiden Univ Med Ctr, Dept Pathol, NL-2333 ZA Leiden, Netherlands
[3] Leiden Univ Med Ctr, Dept Gastroenterol & Hepatol, NL-2333 ZA Leiden, Netherlands
[4] Leiden Univ Med Ctr, Dept Infect Dis, NL-2333 ZA Leiden, Netherlands
[5] Amsterdam Univ Med Ctr Locat AMC, Dept Pathol, NL-1105 AZ Amsterdam, Netherlands
关键词
Small intestine-neuroendocrine tumors; Mismatch repair deficiency; Lynch syndrome; MUTYH; Cancer genetics; MICROSATELLITE INSTABILITY; MOLECULAR PATHWAYS; GERMLINE MUTATION; RISK-FACTORS; CANCER; SURVEILLANCE; CARCINOMAS; MANAGEMENT; NEOPLASMS; DELETIONS;
D O I
10.1016/j.humpath.2022.04.003
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Small intestine-neuroendocrine tumors (SI-NETs) are one of the most common tumors of the small bowel. Despite an increasing incidence, the exact mechanisms driving underlying pathology remain to be determined. Interestingly, recent studies linked the development of (SI-)NETs to both Lynch syndrome (LS) and MUTYH variants. If confirmed, these associations would have important consequences for treatment. In this study we therefore investigated the prevalence of mismatch repair (MMR) deficiency and MUTYH variants in 64 primary resected SI-NETs. Immunohistochemistry was used to assess the expression of the MMR genes, and competitive allele-specific PCR (KASPar) targeting two hotspot MUTYH variants [p.(Tyr179Cys), p.(Gly396Asp)] was performed to determine their prevalence in SI-NETs. Strikingly, all 64 SI-NETs stained positive for MSH6 and PMS2, indicating MMR proficiency. In addition, no MUTYH hotspot variant was found in any of the 64 SI-NETs. As such, these results do not support an association between SI-NET development and LS or MUTYH variants. In order to gain insight into SI-NET pathogenesis and optimally manage patients, future research should therefore focus on other candidate genes. (c) 2022 Published by Elsevier Inc
引用
收藏
页码:11 / 17
页数:7
相关论文
共 50 条
  • [31] Mismatch repair protein status of colorectal small cell neuroendocrine carcinomas
    Stelow, EB
    Moskaluk, CH
    Mills, SE
    MODERN PATHOLOGY, 2006, 19 : 120A - 120A
  • [32] Mismatch repair protein status of colorectal small cell neuroendocrine carcinomas
    Stelow, EB
    Moskaluk, CH
    Mills, SE
    LABORATORY INVESTIGATION, 2006, 86 : 120A - 120A
  • [33] The mismatch repair protein status of colorectal small cell neuroendocrine carcinomas
    Stelow, Edward B.
    Moskaluk, Christopher A.
    Mills, Stacey E.
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2006, 30 (11) : 1401 - 1404
  • [34] Relationship of microsatellite instability to mismatch repair deficiency in malignant tumors of dogs
    Inanaga, Sakuya
    Igase, Masaya
    Sakai, Yusuke
    Hagimori, Kenji
    Sunahara, Hiroshi
    Horikirizono, Hiro
    Itamoto, Kazuhito
    Baba, Kenji
    Ohsato, Yoshiharu
    Mizuno, Takuya
    JOURNAL OF VETERINARY INTERNAL MEDICINE, 2022, 36 (05) : 1760 - 1769
  • [35] PD-1 blockade in tumors with mismatch repair deficiency.
    Le, Dung T.
    Uram, Jennifer N.
    Wang, Hao
    Bartlett, Bjarne
    Kemberling, Holly
    Eyring, Aleksandra
    Skora, Andrew
    Azad, Nilofer Saba
    Laheru, Daniel A.
    Donehower, Ross C.
    Luber, Brandon
    Crocenzi, Todd S.
    Fisher, George A.
    Duffy, Steve M.
    Lee, James J.
    Koshiji, Minori
    Eshleman, James R.
    Anders, Robert A.
    Vogelstein, Bert
    Diaz, Luis A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [36] PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
    Le, D. T.
    Uram, J. N.
    Wang, H.
    Bartlett, B. R.
    Kemberling, H.
    Eyring, A. D.
    Skora, A. D.
    Luber, B. S.
    Azad, N. S.
    Laheru, D.
    Biedrzycki, B.
    Donehower, R. C.
    Zaheer, A.
    Fisher, G. A.
    Crocenzi, T. S.
    Lee, J. J.
    Duffy, S. M.
    Goldberg, R. M.
    de la Chapelle, A.
    Koshiji, M.
    Bhaijee, F.
    Huebner, T.
    Hruban, R. H.
    Wood, L. D.
    Cuka, N.
    Pardoll, D. M.
    Papadopoulos, N.
    Kinzler, K. W.
    Zhou, S.
    Cornish, T. C.
    Taube, J. M.
    Anders, R. A.
    Eshleman, J. R.
    Vogelstein, B.
    Diaz, L. A., Jr.
    NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (26): : 2509 - 2520
  • [37] Neoadjuvant immunotherapy in gastrointestinal tumors with mismatch repair deficiency: An institutional analysis
    Chakrabarti, S.
    Parish, M.
    Ruggeri, A.
    Shreenivas, A.
    Kamgar, M.
    Sriram, D.
    Peterson, C.
    Ridolfi, T.
    Ludwig, K.
    Alqwasmi, A.
    Mooney, C.
    Burfeind, J.
    Clarke, C.
    Christians, K.
    Gamblin, T.
    George, B.
    Thomas, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S371 - S371
  • [38] Small Intestine Neuroendocrine Tumors: Frequently of Unrecognized Primary Site and Multifocal
    Javeed, Zafir
    Wang, Yucheng
    Donner, David B.
    Bergsland, Emily K.
    Warren, Robert S.
    Nakakura, Eric K.
    PANCREAS, 2015, 44 (02) : 353 - 354
  • [39] Incidence and Prognosis of Extramural Venous Invasion in Small Intestine Neuroendocrine Tumors
    Liu, Qingqing
    Ko, Huai-Bin Mabel
    Zhu, Hongfa
    Harpaz, Noam
    Polydorides, Alexandros D.
    MODERN PATHOLOGY, 2017, 30 : 183A - 183A
  • [40] Genetic heterogeneity of primary lesion and metastasis in small intestine neuroendocrine tumors
    Dirk Walter
    Patrick N. Harter
    Florian Battke
    Ria Winkelmann
    Markus Schneider
    Katharina Holzer
    Christine Koch
    Jörg Bojunga
    Stefan Zeuzem
    Martin Leo Hansmann
    Jan Peveling-Oberhag
    Oliver Waidmann
    Scientific Reports, 8